4,4,5,5-Tetramethyl-2-(4-methylbenzyl)-1,3,2-dioxaborolane, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-5 MS Ultra, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

5-ETHENYL-2-FLUORO-PYRIDINE, 95.0%, 10g

Tetrahydro-2H-pyran-4-sulfonyl chloride, 95.0%, 5g

1-(3,5-DICHLOROPYRIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE, 95.0%, 1g

4-Amino-5-bromo-2-chloropyrimidine, 95.0%, 100g

2'-Chloro-4'-fluoroacetanilide>98.0%(GC)5g

Heptafluorobutyric Acid (ca. 0.5mol/L in Water) [Ion-Pair Reagent for LC-MS]10mL

2-(2,6-DIOXOPIPERIDIN-3-YL)-5,6-DIFLUOROISOINDOLINE-1,3-DIONE, 95%, 1g

Ethyl 4,4,4-trifluorocrotonate, 98.0%, 100g

Rotilabo®-Gewindefläschchen ND10, 1,5 ml, Klarglas mit Beschriftungsfeld, 100 Stück

S-Benzyl-L-cysteine>98.0%(HPLC)(T)1g

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine>97.0%(HPLC)(N)250mg